WEST PHARMACEUTICAL SERV INC
Reported by BILL & MELINDA GATES FOUNDATION TRUST
Reported 444,500 shares, unchanged from the prior quarter.
Reported value -8.9%; share count 0.0% vs. the prior quarter.
Reported position value by quarter
Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.
| Date | Holding Value |
|---|---|
| 2025-03-31 | 99514660 |
| 2025-06-30 | 97256600 |
| 2025-09-30 | 116605685 |
| 2025-12-31 | 122299730 |
| 2026-03-31 | 111409480 |
| 2026-06-30 | 159575500 |
Quarterly position history
How this manager's reported quarter-end position changed over time.
| Quarter | Activity | Shares | Change | % of reported 13F | Reported value | Filed | Source filing |
|---|---|---|---|---|---|---|---|
| Q2 2026 | Unchanged | 444,500 | 0 (0.0%) | 0.46% | $159,575,500 | 2026-08-14 | |
| Q1 2026 | Unchanged | 444,500 | 0 (0.0%) | 0.35% | $111,409,480 | 2026-05-15 | |
| Q4 2025 | Unchanged | 444,500 | 0 (0.0%) | 0.35% | $122,299,730 | 2026-02-17 | |
| Q3 2025 | Unchanged | 444,500 | 0 (0.0%) | 0.32% | $116,605,685 | 2025-11-14 | |
| Q2 2025 | Unchanged | 444,500 | 0 (0.0%) | 0.2% | $97,256,600 | 2025-08-14 | |
| Q1 2025 | New | 444,500 | +444,500 (0.0%) | 0.24% | $99,514,660 | 2025-05-15 |
Who else reported the position
887 managers reported WEST PHARMACEUTICAL SERV INC for Q1 2026.
| Manager | Activity | Shares | Change | % of reported 13F | Reported value | Tenure |
|---|---|---|---|---|---|---|
| BlackRock Inc | Added | 6,836,714 | +236,979 | 0.03% | $1,713,554,040 | 7 qtrs |
| VANGUARD CAPITAL MANAGEMENT LLC | New | 4,683,286 | +4,683,286 | 0.03% | $1,173,818,803 | 1 qtr |
| VANGUARD PORTFOLIO MANAGEMENT LLC | New | 4,094,009 | +4,094,009 | 0.05% | $1,026,122,416 | 1 qtr |
| STATE STREET CORPORATION | Added | 3,293,778 | +41,758 | 0.03% | $825,552,518 | 52 qtrs |
| Artisan Partners Limited Partnership | Reduced | 2,657,893 | -192,508 | 1.07% | $666,174,221 | 35 qtrs |
| THE BANK OF NEW YORK MELLON CORPORATION | Reduced | 2,465,858 | -196,177 | 0.11% | $618,042,720 | 52 qtrs |
| T Rowe Price Investment Management Inc | Added | 2,340,403 | +1,165,441 | 0.4% | $586,599,000 | 15 qtrs |
| GENERATION INVESTMENT MANAGEMENT LLP | Added | 2,243,976 | +682,107 | 5.04% | $562,430,145 | 4 qtrs |
| GEODE CAPITAL MANAGEMENT LLC | Added | 1,912,455 | +43,369 | 0.03% | $477,525,250 | 52 qtrs |
| MORGAN STANLEY | Reduced | 1,458,282 | -73,576 | 0.02% | $365,504,513 | 52 qtrs |
Filing details and methodology As reported
- Report period
- March 31, 2026
- Filed
- May 15, 2026
- Filing type
- 13F-HR
- Position type
- COM
Voting authority reported
- Sole
- 444,500
- Shared
- 0
- None
- 0
“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.
Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.